
ECL Stock: Growth, Valuation and Key Risks
Ecolab combines a recurring-revenue service model with 12.7% reported revenue growth and a strong analyst consensus. Its premium valuation, recent negative earnings growth and debt load complicate the outlook, while the next earnings report is scheduled for February 9, 2027.
Executive Summary
Investment Thesis: Ecolab sells water, hygiene and infection-prevention products and services to customers across a broad range of industries, supporting a recurring and service-intensive business model. The latest supplied data show 12.7% revenue growth and a 20.7% return on equity, but earnings growth is negative and the stock trades at a trailing P/E of 41.74. Analyst targets indicate moderate potential upside, while a high valuation and material debt remain important counterweights. This is a mixed setup, not a straightforward read-through from the favorable analyst consensus.
Current Price: $309.27 as of Friday, November 13 | Key Metric: Forward P/E of 32.88 | Stance: NEUTRAL
US stock markets are closed on Saturday, November 14. The supplied price and change data correspond to the last reported close: $309.27, up $4.86 or 1.60% from the previous close of $304.41. The next regular trading session is Monday, November 16.
Company Overview
Ecolab Inc. provides water treatment, cleaning, sanitation and infection-prevention products and services to customers in industries such as food service, healthcare, hospitality, manufacturing and energy. Its offer often combines chemical products, equipment, monitoring and on-site expertise, rather than relying on product sales alone.
Key Products & Competitive Position
- Core Business: Water management, cleaning and sanitation solutions for commercial, industrial and institutional customers.
- Key Products: Water treatment and process-management services, cleaning and sanitizing chemicals, food safety programs, and healthcare and infection-prevention solutions.
- Competitive Moat: Customer-specific systems, technical service and the operational cost of switching providers can support long relationships. These advantages are meaningful, but they do not eliminate competition or protect the company from cost and demand pressures.
Recent Developments
Recent supplied headlines focus on institutional ownership disclosures rather than a major change in Ecolab’s strategy. AlphaCore Capital reportedly increased its position by 14.2%, and Commonwealth Equity Services grew its stake by 7.2%; Candriam S.C.A. reduced its holdings by 46.2%. Such filings indicate changes in individual managers’ positions, not a unified view of the company, and the headlines do not establish why those decisions were made. The latest reported quarter was September 30, 2026.
Financial Snapshot
Metrics are drawn from the supplied data, which include more than one source and some small differences. For example, the supplied EPS is $7.43, while the Yahoo Finance snapshot lists trailing EPS of $7.47 and return on equity of 20.77%. The differences are modest, but readers should check the latest company filings and market data when using these figures.
Revenue & Earnings Trends
The data snapshot reports total revenue of approximately $17.37 billion and revenue growth of 12.7%. That pace is a positive indicator, although the supplied earnings measures are less encouraging: earnings growth is listed at -4.9%, and quarterly earnings growth at -5.8%. Gross margin is 44.04%, while profit margin is 11.99%. Taken together, these figures suggest that sales growth has not yet translated into comparable growth in earnings, making margins and cost control important items to monitor.
Free cash flow is listed at approximately $1.44 billion, compared with operating cash flow of about $3.03 billion. These figures indicate cash generation, but the difference between the two also reflects investment needs and other cash uses. The available data do not provide a full period-by-period trend, so one snapshot should not be treated as proof of a durable improvement or deterioration.
Balance Sheet Highlights
Ecolab’s reported current ratio is 1.11, and its quick ratio is 0.77. Those figures point to limited short-term liquidity cushion compared with a company holding a larger pool of liquid assets. The snapshot lists total debt of approximately $13.94 billion, cash of $722 million and debt to equity of 133.33%. Debt does not by itself establish financial distress, but it increases the importance of steady cash flow, refinancing conditions and disciplined capital allocation. Investors assessing resilience can track debt repayment and cash conversion alongside earnings.
Valuation Analysis
Current Valuation Metrics
The supplied trailing P/E of 41.74 is high in absolute terms, while the forward P/E of 32.88 is lower because estimates assume higher future earnings. The PEG ratio of 2.42 and enterprise value to EBITDA of 23.34 also point to a valuation that depends on continued execution and earnings improvement. A calculated price-to-sales ratio of roughly 5.0 uses the supplied $86.74 billion market capitalization and $17.37 billion revenue; it is an approximation, not a directly supplied market quote.
Historical Comparison
A reliable five-year average valuation and a directly comparable industry multiple were not included in the supplied material. It would be misleading to claim a precise premium or discount to either benchmark. The available two-year price snapshot reports an average close of $264.50 and a total return of 27.54%, but that performance data cannot substitute for a historical earnings multiple comparison.
Fair Value Estimate
Analyst price targets supplied for this report have a mean of $339.91 and a median of $345, compared with the $309.27 Friday close. The mean represents approximately 9.9% implied upside, but it is a consensus estimate, not a guaranteed outcome or an independent fair-value calculation. Another supplied market-data snapshot shows a lower mean target of $330.57, underlining that target estimates vary by source and coverage set.
A discounted cash flow assessment would require assumptions for future revenue, margins, taxes, investment, discount rates and terminal growth that are not available here. Given the premium earnings multiples, the valuation is sensitive to whether earnings growth recovers and whether cash generation remains durable. The data support describing ECL as a high-expectation stock, not assigning a precise intrinsic value.
Competitive Landscape
Market Position
Market Share: Not specified in the supplied data; the markets served are fragmented | Ranking: A leading global provider of water, hygiene and infection-prevention solutions
Ecolab competes across several related markets rather than one narrowly defined category. Its service footprint and customer-specific programs distinguish it from suppliers focused mainly on products, although customers may use more than one provider or bring some tasks in-house. No comparable market-share figures were supplied, so a numerical ranking would be imprecise.
Key Competitors
These companies are not direct substitutes across Ecolab’s entire portfolio. Private businesses and specialist providers also compete in parts of water treatment, food safety, sanitation and industrial cleaning.
Competitive Advantages
- Service Relationships: On-site expertise and continuing service can make Ecolab part of customers’ daily operations, supporting repeat business.
- Integrated Offer: Combining chemicals, equipment, monitoring and technical advice can address problems beyond a single product purchase.
- Broad Customer Base: Exposure across multiple industries may reduce dependence on any one end market, though it cannot insulate the company from a broad slowdown.
Earnings Track Record
Last 4 Quarters: 0 confirmed beats / 1 reported miss at consensus. Other quarter-by-quarter comparisons were not supplied.
Recent Earnings History
The Q3 2026 supplied figures show EPS of $2.18 against an estimate of $2.18, which is mathematically in line even though the source labels it a miss. The apparent difference may reflect rounding or a source-specific definition. With no other quarterly actuals and estimates included, a four-quarter beat rate cannot be responsibly inferred.
Guidance Trend
The next listed earnings date is February 9, 2027, with estimated EPS of $2.19. No management guidance revisions were provided. The comparison between actual results, market expectations and management commentary at the next report will help clarify whether the negative earnings-growth figures are temporary or persistent.
Analyst Sentiment
Consensus Rating: , as reported by the supplied analyst-consensus data
The supplied recommendations cover 25 analysts, with 21 of them in the Strong Buy or Buy categories and four at Hold. No Sell or Strong Sell ratings are listed. These are third-party opinions, not a substitute for assessing valuation, business risks or your own financial circumstances.
Price Targets
- Low: $305
- Mean: $339.91 (+9.9% implied upside from $309.27)
- High: $380
The supplied target range is wide, from just below the Friday close to materially above it. A separate Yahoo Finance snapshot lists a mean target of $330.57, low of $300 and high of $360, with 21 analyst opinions and a Buy consensus. Target coverage and update timing can differ, so the two sets should not be combined as if they were one forecast.
Recent Analyst Actions
No specific analyst upgrades, downgrades or target changes were included. The consensus data are favorable, but the available material does not show whether ratings have recently shifted or how analysts have adjusted their earnings assumptions.
Recent News & Catalysts
Key Developments
- AlphaCore Capital disclosed a larger position: A November 11 report says the firm raised its ECL position by 14.2% in a reported quarter. The filing describes ownership activity, not the firm’s rationale.
- Commonwealth Equity Services grew its stake: A November 10 report says its position increased by 7.2% during the third quarter.
- Candriam reduced its holdings: A November 9 report says the firm cut its position by 46.2%. These differing institutional moves are not, by themselves, reliable signals of future share performance.
Upcoming Catalysts
Next Earnings: February 9, 2027, estimated EPS $2.19 | Key Events: Q4 and full-year results, 2027 outlook, revenue growth, margin progression, cash flow and debt updates
The next earnings release is the clearest scheduled company-specific catalyst in the supplied information. Market participants may also monitor customer demand, input costs, currency effects and the pace of earnings recovery. No other confirmed event dates were provided.
Technical Outlook
Current Price: $309.27 as of Friday, November 13 vs 52-Week High: $318.93 (-3.0% from high)
Trend Analysis
The share price is near the upper end of its supplied 52-week range of $243.15 to $318.93, about 3.0% below the high and 27.2% above the low. The two-year snapshot reports a 27.54% total return, though that period does not establish the current short-term trend. No moving averages, volume pattern, relative-strength readings or chart history were provided, so this assessment is limited to the supplied range and price.
For context, the reported Friday change of $4.86, or 1.60%, is a comparison with the previous close, not a statement about Saturday trading. US markets are closed for the weekend; the next session is Monday, November 16.
Key Levels
- Resistance: $318.93, the supplied 52-week high; $339.91, the supplied analyst mean target, which is not a technical resistance level.
- Support: $305, the low analyst target and a reference point rather than chart-confirmed support; $243.15, the supplied 52-week low.
Bull vs Bear Case
Bull Case
- Recurring customer activity: Water, cleaning and sanitation programs can produce repeat demand and embed services into customer operations.
- Sales and returns: The data report 12.7% revenue growth and ROE of 20.70%, indicating growth and efficient use of equity in the measured period.
- Analyst expectations: The supplied mean target of $339.91 is about 9.9% above the Friday close, and most listed analysts rate the shares Buy or Strong Buy.
Bull Scenario Reference: $380, the supplied analyst high target, not an independent forecast
Bear Case
- Elevated valuation: A trailing P/E of 41.74 and EV/EBITDA of 23.34 leave less room for disappointing execution if earnings do not improve.
- Slower earnings: The supplied earnings-growth readings are negative, and the latest EPS was reported at consensus despite being labeled a miss.
- Financial obligations: Debt of about $13.94 billion and a 0.77 quick ratio make cash generation and balance-sheet management relevant risks.
Bear Scenario Reference: $305, the supplied analyst low target, not an independent forecast
These reference points are analyst targets, not price predictions from this report. Actual outcomes can fall outside the range, particularly if economic conditions, customer demand or earnings assumptions change.
Risks to Consider
- Valuation Risk: Premium earnings and enterprise-value multiples increase sensitivity to changes in growth expectations, interest rates and quarterly results.
- Competitive Risk: Large suppliers, specialist firms and in-house customer capabilities can pressure pricing or limit contract wins in individual product categories.
- Macro Risk: Industrial activity, hospitality and food-service demand, customer budgets, foreign exchange and input costs may affect sales and margins.
- Execution Risk: Ecolab must sustain service quality, integrate its product and technology offerings, manage costs and convert revenue growth into earnings and cash flow.
- Balance-Sheet Risk: Material debt relative to equity and modest quick liquidity increase the value of predictable cash generation and prudent financing.
- Data Risk: The supplied sources differ on EPS and analyst targets, and detailed historical earnings and valuation benchmarks are absent. Verify key figures against company filings and current market sources.
Bottom Line
Investment Verdict: NEUTRAL
Ecolab has a differentiated service-led business, reported revenue growth and favorable analyst sentiment, but its high valuation and negative earnings-growth data warrant caution in interpreting the target-price upside. The evidence supports a balanced view: the next earnings report and the company’s ability to turn sales growth into sustained earnings and cash flow are central to the outlook. This analysis is informational and is not investment advice.
Action Items for Investors
- Long-term investors: Review the company’s filings for organic growth, margin trends, cash conversion and debt reduction, then compare those results with the premium valuation. Consider how much execution risk your own portfolio can tolerate.
- Short-term traders: Treat $318.93 as the observed 52-week high, not a guaranteed technical level. The supplied information lacks chart indicators, so any short-term interpretation should account for price volatility and Monday’s market reopening.
- Risk management: Check the reporting date and source behind price targets and EPS estimates. Avoid relying on analyst consensus alone, and account for the possibility that actual results differ from expectations.
What to Watch This Week
- Whether ECL opens Monday, November 16, near Friday’s $309.27 close or gaps in response to weekend developments.
- Any company updates or analyst estimate changes that clarify the reported negative earnings-growth trend.
- New filings or commentary on institutional ownership, while recognizing that individual stake changes do not establish a broad market view.
Sources
Share this report
Share this article
Spread the word on social media
Think ECL will outperform? Prove it.
Free practice contests — earn Alpha CoinsExplore More Content
Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.
Spotted something wrong? Report an error.